nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—SLC22A4—Crohn's disease	0.404	0.571	CbGaD
Cimetidine—SLC22A5—Crohn's disease	0.303	0.429	CbGaD
Cimetidine—SLC22A8—Mercaptopurine—Crohn's disease	0.0575	0.51	CbGbCtD
Cimetidine—CYP3A5—Sulfasalazine—Crohn's disease	0.0224	0.198	CbGbCtD
Cimetidine—CYP2C19—Prednisone—Crohn's disease	0.0144	0.128	CbGbCtD
Cimetidine—ABCB1—Prednisone—Crohn's disease	0.0116	0.103	CbGbCtD
Cimetidine—ABCB11—bile—Crohn's disease	0.0075	0.302	CbGeAlD
Cimetidine—CYP3A4—Prednisone—Crohn's disease	0.00697	0.0617	CbGbCtD
Cimetidine—Hepatic insufficiency—Azathioprine—Crohn's disease	0.00675	0.0958	CcSEcCtD
Cimetidine—Alopecia reversible—Mesalazine—Crohn's disease	0.00419	0.0595	CcSEcCtD
Cimetidine—Bone marrow depression—Mercaptopurine—Crohn's disease	0.0026	0.0369	CcSEcCtD
Cimetidine—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00227	0.0322	CcSEcCtD
Cimetidine—Liver injury—Mercaptopurine—Crohn's disease	0.00208	0.0296	CcSEcCtD
Cimetidine—Bone marrow depression—Azathioprine—Crohn's disease	0.00155	0.022	CcSEcCtD
Cimetidine—Bone marrow depression—Mesalazine—Crohn's disease	0.00141	0.02	CcSEcCtD
Cimetidine—Nephritis interstitial—Mesalazine—Crohn's disease	0.00141	0.02	CcSEcCtD
Cimetidine—Hepatotoxicity—Azathioprine—Crohn's disease	0.00135	0.0192	CcSEcCtD
Cimetidine—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.00124	0.0176	CcSEcCtD
Cimetidine—Liver injury—Azathioprine—Crohn's disease	0.00124	0.0176	CcSEcCtD
Cimetidine—Hepatotoxicity—Mesalazine—Crohn's disease	0.00123	0.0175	CcSEcCtD
Cimetidine—Liver injury—Mesalazine—Crohn's disease	0.00113	0.016	CcSEcCtD
Cimetidine—Pancreatitis—Mercaptopurine—Crohn's disease	0.00108	0.0153	CcSEcCtD
Cimetidine—FMO1—mammalian vulva—Crohn's disease	0.00107	0.043	CbGeAlD
Cimetidine—Pancytopenia—Mercaptopurine—Crohn's disease	0.00104	0.0148	CcSEcCtD
Cimetidine—SLC22A3—mouth—Crohn's disease	0.001	0.0403	CbGeAlD
Cimetidine—Aplastic anaemia—Azathioprine—Crohn's disease	0.000981	0.0139	CcSEcCtD
Cimetidine—Musculoskeletal pain—Mesalazine—Crohn's disease	0.000963	0.0137	CcSEcCtD
Cimetidine—FMO1—digestive system—Crohn's disease	0.000938	0.0377	CbGeAlD
Cimetidine—FMO3—mammalian vulva—Crohn's disease	0.000924	0.0372	CbGeAlD
Cimetidine—HRH2—skin of body—Crohn's disease	0.000902	0.0363	CbGeAlD
Cimetidine—Aplastic anaemia—Mesalazine—Crohn's disease	0.000893	0.0127	CcSEcCtD
Cimetidine—Hepatic failure—Azathioprine—Crohn's disease	0.000844	0.012	CcSEcCtD
Cimetidine—ABCB11—digestive system—Crohn's disease	0.00082	0.033	CbGeAlD
Cimetidine—Alopecia—Mercaptopurine—Crohn's disease	0.000778	0.011	CcSEcCtD
Cimetidine—Disorientation—Mesalazine—Crohn's disease	0.000772	0.011	CcSEcCtD
Cimetidine—Hepatic failure—Mesalazine—Crohn's disease	0.000769	0.0109	CcSEcCtD
Cimetidine—SLC22A11—digestive system—Crohn's disease	0.000757	0.0304	CbGeAlD
Cimetidine—SLC22A7—digestive system—Crohn's disease	0.000739	0.0297	CbGeAlD
Cimetidine—Renal impairment—Mesalazine—Crohn's disease	0.000726	0.0103	CcSEcCtD
Cimetidine—HRH2—digestive system—Crohn's disease	0.000721	0.029	CbGeAlD
Cimetidine—Leukopenia—Mercaptopurine—Crohn's disease	0.000686	0.00974	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000683	0.00969	CcSEcCtD
Cimetidine—SLC22A2—digestive system—Crohn's disease	0.000658	0.0264	CbGeAlD
Cimetidine—Arthralgia—Mercaptopurine—Crohn's disease	0.000653	0.00926	CcSEcCtD
Cimetidine—Blood creatinine increased—Mesalazine—Crohn's disease	0.000647	0.00918	CcSEcCtD
Cimetidine—Pancreatitis—Azathioprine—Crohn's disease	0.000643	0.00912	CcSEcCtD
Cimetidine—SLC47A1—mammalian vulva—Crohn's disease	0.000635	0.0255	CbGeAlD
Cimetidine—Pancytopenia—Azathioprine—Crohn's disease	0.000622	0.00883	CcSEcCtD
Cimetidine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000612	0.00869	CcSEcCtD
Cimetidine—Pneumonia—Azathioprine—Crohn's disease	0.000588	0.00834	CcSEcCtD
Cimetidine—Pancreatitis—Mesalazine—Crohn's disease	0.000585	0.00831	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000579	0.00822	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00057	0.00809	CcSEcCtD
Cimetidine—Pancytopenia—Mesalazine—Crohn's disease	0.000567	0.00805	CcSEcCtD
Cimetidine—SLC22A3—smooth muscle tissue—Crohn's disease	0.000562	0.0226	CbGeAlD
Cimetidine—Neutropenia—Mesalazine—Crohn's disease	0.000558	0.00792	CcSEcCtD
Cimetidine—SLC47A1—digestive system—Crohn's disease	0.000557	0.0224	CbGeAlD
Cimetidine—Agranulocytosis—Azathioprine—Crohn's disease	0.000545	0.00774	CcSEcCtD
Cimetidine—FMO1—lymph node—Crohn's disease	0.000536	0.0215	CbGeAlD
Cimetidine—Pneumonia—Mesalazine—Crohn's disease	0.000535	0.0076	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000528	0.00749	CcSEcCtD
Cimetidine—Renal failure—Mesalazine—Crohn's disease	0.000523	0.00743	CcSEcCtD
Cimetidine—SLC22A3—mammalian vulva—Crohn's disease	0.000506	0.0204	CbGeAlD
Cimetidine—Agranulocytosis—Mesalazine—Crohn's disease	0.000497	0.00705	CcSEcCtD
Cimetidine—Erythema multiforme—Azathioprine—Crohn's disease	0.000496	0.00704	CcSEcCtD
Cimetidine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000494	0.00702	CcSEcCtD
Cimetidine—SLC22A4—digestive system—Crohn's disease	0.000488	0.0196	CbGeAlD
Cimetidine—Hepatitis—Mesalazine—Crohn's disease	0.000478	0.00678	CcSEcCtD
Cimetidine—Alopecia—Azathioprine—Crohn's disease	0.000464	0.00658	CcSEcCtD
Cimetidine—FMO3—lymph node—Crohn's disease	0.000463	0.0186	CbGeAlD
Cimetidine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000461	0.00654	CcSEcCtD
Cimetidine—Erythema multiforme—Mesalazine—Crohn's disease	0.000452	0.00641	CcSEcCtD
Cimetidine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000428	0.00607	CcSEcCtD
Cimetidine—Alopecia—Mesalazine—Crohn's disease	0.000422	0.00599	CcSEcCtD
Cimetidine—HRH2—lymph node—Crohn's disease	0.000412	0.0166	CbGeAlD
Cimetidine—Malaise—Azathioprine—Crohn's disease	0.000412	0.00584	CcSEcCtD
Cimetidine—Flatulence—Mesalazine—Crohn's disease	0.00041	0.00582	CcSEcCtD
Cimetidine—Leukopenia—Azathioprine—Crohn's disease	0.000409	0.0058	CcSEcCtD
Cimetidine—SLC22A5—skin of body—Crohn's disease	0.000404	0.0162	CbGeAlD
Cimetidine—Vomiting—Mercaptopurine—Crohn's disease	0.000398	0.00564	CcSEcCtD
Cimetidine—Rash—Mercaptopurine—Crohn's disease	0.000394	0.0056	CcSEcCtD
Cimetidine—Dermatitis—Mercaptopurine—Crohn's disease	0.000394	0.00559	CcSEcCtD
Cimetidine—Myalgia—Azathioprine—Crohn's disease	0.000389	0.00552	CcSEcCtD
Cimetidine—Arthralgia—Azathioprine—Crohn's disease	0.000389	0.00552	CcSEcCtD
Cimetidine—Malaise—Mesalazine—Crohn's disease	0.000375	0.00532	CcSEcCtD
Cimetidine—Leukopenia—Mesalazine—Crohn's disease	0.000372	0.00528	CcSEcCtD
Cimetidine—Nausea—Mercaptopurine—Crohn's disease	0.000372	0.00527	CcSEcCtD
Cimetidine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000365	0.00518	CcSEcCtD
Cimetidine—CYP2C19—digestive system—Crohn's disease	0.000358	0.0144	CbGeAlD
Cimetidine—Psychotic disorder—Prednisone—Crohn's disease	0.000357	0.00506	CcSEcCtD
Cimetidine—Arthralgia—Mesalazine—Crohn's disease	0.000354	0.00503	CcSEcCtD
Cimetidine—Myalgia—Mesalazine—Crohn's disease	0.000354	0.00503	CcSEcCtD
Cimetidine—Anxiety—Mesalazine—Crohn's disease	0.000353	0.00501	CcSEcCtD
Cimetidine—Confusional state—Mesalazine—Crohn's disease	0.000342	0.00486	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00034	0.00482	CcSEcCtD
Cimetidine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000339	0.00482	CcSEcCtD
Cimetidine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000332	0.00472	CcSEcCtD
Cimetidine—Tachycardia—Mesalazine—Crohn's disease	0.000331	0.0047	CcSEcCtD
Cimetidine—SLC22A5—digestive system—Crohn's disease	0.000323	0.013	CbGeAlD
Cimetidine—SLC47A1—lymph node—Crohn's disease	0.000318	0.0128	CbGeAlD
Cimetidine—Pancreatitis—Prednisone—Crohn's disease	0.00031	0.00439	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000309	0.00439	CcSEcCtD
Cimetidine—Feeling abnormal—Azathioprine—Crohn's disease	0.000307	0.00436	CcSEcCtD
Cimetidine—Somnolence—Mesalazine—Crohn's disease	0.000302	0.00428	CcSEcCtD
Cimetidine—Neutropenia—Prednisone—Crohn's disease	0.000295	0.00419	CcSEcCtD
Cimetidine—Body temperature increased—Azathioprine—Crohn's disease	0.000295	0.00418	CcSEcCtD
Cimetidine—Fatigue—Mesalazine—Crohn's disease	0.000293	0.00415	CcSEcCtD
Cimetidine—CYP1A2—digestive system—Crohn's disease	0.000293	0.0118	CbGeAlD
Cimetidine—Erectile dysfunction—Prednisone—Crohn's disease	0.000291	0.00413	CcSEcCtD
Cimetidine—Constipation—Mesalazine—Crohn's disease	0.00029	0.00412	CcSEcCtD
Cimetidine—CYP3A5—digestive system—Crohn's disease	0.000282	0.0113	CbGeAlD
Cimetidine—Feeling abnormal—Mesalazine—Crohn's disease	0.00028	0.00397	CcSEcCtD
Cimetidine—SLC22A4—lymph node—Crohn's disease	0.000279	0.0112	CbGeAlD
Cimetidine—CYP2C9—digestive system—Crohn's disease	0.000278	0.0112	CbGeAlD
Cimetidine—Hypersensitivity—Azathioprine—Crohn's disease	0.000275	0.0039	CcSEcCtD
Cimetidine—Body temperature increased—Mesalazine—Crohn's disease	0.000268	0.00381	CcSEcCtD
Cimetidine—CYP2E1—lymphoid tissue—Crohn's disease	0.000266	0.0107	CbGeAlD
Cimetidine—CYP2E1—digestive system—Crohn's disease	0.000263	0.0106	CbGeAlD
Cimetidine—Bradycardia—Prednisone—Crohn's disease	0.000257	0.00365	CcSEcCtD
Cimetidine—Diarrhoea—Azathioprine—Crohn's disease	0.000255	0.00362	CcSEcCtD
Cimetidine—SLC22A3—lymph node—Crohn's disease	0.000254	0.0102	CbGeAlD
Cimetidine—Hallucination—Prednisone—Crohn's disease	0.000252	0.00357	CcSEcCtD
Cimetidine—Hypersensitivity—Mesalazine—Crohn's disease	0.00025	0.00355	CcSEcCtD
Cimetidine—Dizziness—Azathioprine—Crohn's disease	0.000246	0.0035	CcSEcCtD
Cimetidine—Asthenia—Mesalazine—Crohn's disease	0.000244	0.00346	CcSEcCtD
Cimetidine—Vomiting—Azathioprine—Crohn's disease	0.000237	0.00336	CcSEcCtD
Cimetidine—Rash—Azathioprine—Crohn's disease	0.000235	0.00333	CcSEcCtD
Cimetidine—Dermatitis—Azathioprine—Crohn's disease	0.000235	0.00333	CcSEcCtD
Cimetidine—Headache—Azathioprine—Crohn's disease	0.000233	0.00331	CcSEcCtD
Cimetidine—Diarrhoea—Mesalazine—Crohn's disease	0.000232	0.0033	CcSEcCtD
Cimetidine—Dizziness—Mesalazine—Crohn's disease	0.000224	0.00319	CcSEcCtD
Cimetidine—Alopecia—Prednisone—Crohn's disease	0.000223	0.00317	CcSEcCtD
Cimetidine—Nausea—Azathioprine—Crohn's disease	0.000221	0.00314	CcSEcCtD
Cimetidine—Vomiting—Mesalazine—Crohn's disease	0.000216	0.00306	CcSEcCtD
Cimetidine—Rash—Mesalazine—Crohn's disease	0.000214	0.00304	CcSEcCtD
Cimetidine—Dermatitis—Mesalazine—Crohn's disease	0.000214	0.00303	CcSEcCtD
Cimetidine—Headache—Mesalazine—Crohn's disease	0.000213	0.00302	CcSEcCtD
Cimetidine—CYP3A4—digestive system—Crohn's disease	0.000212	0.00851	CbGeAlD
Cimetidine—CYP2D6—digestive system—Crohn's disease	0.000208	0.00838	CbGeAlD
Cimetidine—Agitation—Prednisone—Crohn's disease	0.000202	0.00287	CcSEcCtD
Cimetidine—Nausea—Mesalazine—Crohn's disease	0.000202	0.00286	CcSEcCtD
Cimetidine—Malaise—Prednisone—Crohn's disease	0.000198	0.00282	CcSEcCtD
Cimetidine—ABCB1—epithelium—Crohn's disease	0.000197	0.00792	CbGeAlD
Cimetidine—Myalgia—Prednisone—Crohn's disease	0.000187	0.00266	CcSEcCtD
Cimetidine—Arthralgia—Prednisone—Crohn's disease	0.000187	0.00266	CcSEcCtD
Cimetidine—Anxiety—Prednisone—Crohn's disease	0.000187	0.00265	CcSEcCtD
Cimetidine—SLC22A5—lymph node—Crohn's disease	0.000184	0.00742	CbGeAlD
Cimetidine—Anaphylactic shock—Prednisone—Crohn's disease	0.00018	0.00255	CcSEcCtD
Cimetidine—Tachycardia—Prednisone—Crohn's disease	0.000175	0.00249	CcSEcCtD
Cimetidine—ABCB1—mammalian vulva—Crohn's disease	0.000171	0.00687	CbGeAlD
Cimetidine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000164	0.00232	CcSEcCtD
Cimetidine—Fatigue—Prednisone—Crohn's disease	0.000155	0.0022	CcSEcCtD
Cimetidine—Constipation—Prednisone—Crohn's disease	0.000154	0.00218	CcSEcCtD
Cimetidine—ABCB1—lymphoid tissue—Crohn's disease	0.000152	0.0061	CbGeAlD
Cimetidine—ABCB1—digestive system—Crohn's disease	0.00015	0.00603	CbGeAlD
Cimetidine—Feeling abnormal—Prednisone—Crohn's disease	0.000148	0.0021	CcSEcCtD
Cimetidine—Body temperature increased—Prednisone—Crohn's disease	0.000142	0.00201	CcSEcCtD
Cimetidine—Hypersensitivity—Prednisone—Crohn's disease	0.000132	0.00188	CcSEcCtD
Cimetidine—Asthenia—Prednisone—Crohn's disease	0.000129	0.00183	CcSEcCtD
Cimetidine—Diarrhoea—Prednisone—Crohn's disease	0.000123	0.00174	CcSEcCtD
Cimetidine—Dizziness—Prednisone—Crohn's disease	0.000119	0.00169	CcSEcCtD
Cimetidine—Vomiting—Prednisone—Crohn's disease	0.000114	0.00162	CcSEcCtD
Cimetidine—Rash—Prednisone—Crohn's disease	0.000113	0.00161	CcSEcCtD
Cimetidine—Dermatitis—Prednisone—Crohn's disease	0.000113	0.00161	CcSEcCtD
Cimetidine—Headache—Prednisone—Crohn's disease	0.000113	0.0016	CcSEcCtD
Cimetidine—Nausea—Prednisone—Crohn's disease	0.000107	0.00151	CcSEcCtD
Cimetidine—ABCB1—lymph node—Crohn's disease	8.56e-05	0.00344	CbGeAlD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.69e-05	0.000788	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PLA2G4F—Crohn's disease	6.68e-05	0.000786	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.67e-05	0.000785	CbGpPWpGaD
Cimetidine—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	6.57e-05	0.000773	CbGpPWpGaD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	6.42e-05	0.000756	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—GPR65—Crohn's disease	6.38e-05	0.000751	CbGpPWpGaD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.34e-05	0.000747	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—CCR9—Crohn's disease	6.23e-05	0.000733	CbGpPWpGaD
Cimetidine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	6.04e-05	0.000711	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.03e-05	0.00071	CbGpPWpGaD
Cimetidine—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	5.99e-05	0.000705	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.95e-05	0.000701	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.95e-05	0.000701	CbGpPWpGaD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.91e-05	0.000696	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.89e-05	0.000694	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—GPR65—Crohn's disease	5.79e-05	0.000682	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—TNF—Crohn's disease	5.78e-05	0.00068	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IL10—Crohn's disease	5.78e-05	0.00068	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—MTMR3—Crohn's disease	5.68e-05	0.000668	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—ACKR2—Crohn's disease	5.6e-05	0.000659	CbGpPWpGaD
Cimetidine—SLC22A4—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.56e-05	0.000654	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.55e-05	0.000653	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.55e-05	0.000653	CbGpPWpGaD
Cimetidine—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	5.39e-05	0.000635	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—FADS1—Crohn's disease	5.38e-05	0.000633	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.33e-05	0.000628	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MLN—Crohn's disease	5.31e-05	0.000625	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PLA2G4F—Crohn's disease	5.23e-05	0.000616	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	5.15e-05	0.000606	CbGpPWpGaD
Cimetidine—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	5.12e-05	0.000603	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—GPX4—Crohn's disease	5.03e-05	0.000593	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.03e-05	0.000593	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PLA2G4F—Crohn's disease	5.01e-05	0.00059	CbGpPWpGaD
Cimetidine—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.95e-05	0.000583	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—GCKR—Crohn's disease	4.86e-05	0.000572	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TAGAP—Crohn's disease	4.86e-05	0.000572	CbGpPWpGaD
Cimetidine—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.81e-05	0.000566	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—IL6—Crohn's disease	4.66e-05	0.000549	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.62e-05	0.000544	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—CCR6—Crohn's disease	4.54e-05	0.000535	CbGpPWpGaD
Cimetidine—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.49e-05	0.000529	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.45e-05	0.000524	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—MTMR3—Crohn's disease	4.45e-05	0.000524	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—FADS1—Crohn's disease	4.42e-05	0.000521	CbGpPWpGaD
Cimetidine—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.39e-05	0.000517	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—MTMR3—Crohn's disease	4.26e-05	0.000502	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RSPO3—Crohn's disease	4.24e-05	0.0005	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.2e-05	0.000494	CbGpPWpGaD
Cimetidine—SLC22A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.19e-05	0.000493	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	4.18e-05	0.000492	CbGpPWpGaD
Cimetidine—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.18e-05	0.000492	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—GPX4—Crohn's disease	4.14e-05	0.000488	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—CCR6—Crohn's disease	4.13e-05	0.000486	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.12e-05	0.000485	CbGpPWpGaD
Cimetidine—SLC47A1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.07e-05	0.00048	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SEL1L—Crohn's disease	4.02e-05	0.000474	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	4.01e-05	0.000472	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—PTGER4—Crohn's disease	4e-05	0.000471	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—GCKR—Crohn's disease	4e-05	0.000471	CbGpPWpGaD
Cimetidine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	3.95e-05	0.000465	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.93e-05	0.000462	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.91e-05	0.00046	CbGpPWpGaD
Cimetidine—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.78e-05	0.000445	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.76e-05	0.000443	CbGpPWpGaD
Cimetidine—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.75e-05	0.000441	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	3.73e-05	0.000439	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.71e-05	0.000437	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCR9—Crohn's disease	3.68e-05	0.000433	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—PTGER4—Crohn's disease	3.63e-05	0.000428	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.63e-05	0.000427	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.51e-05	0.000413	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—FADS1—Crohn's disease	3.46e-05	0.000408	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.46e-05	0.000407	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—GPR65—Crohn's disease	3.42e-05	0.000403	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—IL3—Crohn's disease	3.41e-05	0.000401	CbGpPWpGaD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.4e-05	0.000401	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	3.4e-05	0.0004	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—FADS1—Crohn's disease	3.32e-05	0.000391	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—RASGRP1—Crohn's disease	3.3e-05	0.000388	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	3.29e-05	0.000387	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	3.28e-05	0.000386	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.25e-05	0.000383	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.25e-05	0.000383	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—GPX4—Crohn's disease	3.24e-05	0.000382	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.21e-05	0.000378	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.2e-05	0.000376	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	3.16e-05	0.000372	CbGpPWpGaD
Cimetidine—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.15e-05	0.000371	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—GCKR—Crohn's disease	3.13e-05	0.000369	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—GPX4—Crohn's disease	3.11e-05	0.000366	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—IL3—Crohn's disease	3.09e-05	0.000364	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.06e-05	0.00036	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	3.06e-05	0.00036	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	3.03e-05	0.000357	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—GCKR—Crohn's disease	3e-05	0.000354	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—RASGRP1—Crohn's disease	2.99e-05	0.000352	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.86e-05	0.000337	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.86e-05	0.000336	CbGpPWpGaD
Cimetidine—SLC22A4—Transmembrane transport of small molecules—ALB—Crohn's disease	2.82e-05	0.000332	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—MTMR3—Crohn's disease	2.79e-05	0.000329	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—MTMR3—Crohn's disease	2.79e-05	0.000328	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.73e-05	0.000322	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.73e-05	0.000322	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	2.71e-05	0.000319	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.71e-05	0.000319	CbGpPWpGaD
Cimetidine—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.63e-05	0.000309	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—MTMR3—Crohn's disease	2.6e-05	0.000306	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—CXCL8—Crohn's disease	2.59e-05	0.000305	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.56e-05	0.000301	CbGpPWpGaD
Cimetidine—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	2.52e-05	0.000296	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.5e-05	0.000294	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.49e-05	0.000293	CbGpPWpGaD
Cimetidine—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.45e-05	0.000288	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCR6—Crohn's disease	2.44e-05	0.000287	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—IL2RA—Crohn's disease	2.39e-05	0.000281	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	2.38e-05	0.00028	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	2.37e-05	0.00028	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.33e-05	0.000275	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.29e-05	0.00027	CbGpPWpGaD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	2.28e-05	0.000269	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RBX1—Crohn's disease	2.2e-05	0.00026	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—TNF—Crohn's disease	2.2e-05	0.000259	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—FADS1—Crohn's disease	2.18e-05	0.000256	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—FADS1—Crohn's disease	2.17e-05	0.000256	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—IL2RA—Crohn's disease	2.17e-05	0.000255	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—ALB—Crohn's disease	2.16e-05	0.000255	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.15e-05	0.000253	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTGER4—Crohn's disease	2.15e-05	0.000253	CbGpPWpGaD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—ALB—Crohn's disease	2.13e-05	0.000251	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.13e-05	0.000251	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	2.12e-05	0.00025	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	2.06e-05	0.000242	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GPX4—Crohn's disease	2.04e-05	0.00024	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GPX4—Crohn's disease	2.03e-05	0.00024	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.03e-05	0.000239	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—FADS1—Crohn's disease	2.03e-05	0.000238	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—MTMR3—Crohn's disease	2.02e-05	0.000238	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—MTMR3—Crohn's disease	2.02e-05	0.000238	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.99e-05	0.000235	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GCKR—Crohn's disease	1.97e-05	0.000232	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GCKR—Crohn's disease	1.97e-05	0.000231	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—UBE2D1—Crohn's disease	1.93e-05	0.000228	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	1.92e-05	0.000226	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GPX4—Crohn's disease	1.9e-05	0.000223	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—PTGS2—Crohn's disease	1.89e-05	0.000223	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.88e-05	0.000221	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RIPK2—Crohn's disease	1.87e-05	0.000221	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	1.84e-05	0.000216	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GCKR—Crohn's disease	1.83e-05	0.000216	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL3—Crohn's disease	1.83e-05	0.000215	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	1.79e-05	0.000211	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RASGRP1—Crohn's disease	1.77e-05	0.000208	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—MTMR3—Crohn's disease	1.75e-05	0.000206	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.69e-05	0.000199	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.67e-05	0.000197	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.61e-05	0.000189	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—JAK2—Crohn's disease	1.6e-05	0.000189	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SOCS1—Crohn's disease	1.6e-05	0.000189	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.6e-05	0.000189	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—FADS1—Crohn's disease	1.58e-05	0.000186	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—FADS1—Crohn's disease	1.57e-05	0.000185	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—MTMR3—Crohn's disease	1.56e-05	0.000184	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—ALB—Crohn's disease	1.55e-05	0.000182	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—TYK2—Crohn's disease	1.53e-05	0.00018	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—MTMR3—Crohn's disease	1.52e-05	0.000179	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GPX4—Crohn's disease	1.48e-05	0.000174	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GPX4—Crohn's disease	1.47e-05	0.000173	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—CXCL8—Crohn's disease	1.46e-05	0.000172	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—JAK2—Crohn's disease	1.46e-05	0.000172	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.44e-05	0.000169	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.43e-05	0.000168	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GCKR—Crohn's disease	1.43e-05	0.000168	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.42e-05	0.000168	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GCKR—Crohn's disease	1.42e-05	0.000167	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SMAD3—Crohn's disease	1.38e-05	0.000163	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—FADS1—Crohn's disease	1.36e-05	0.00016	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PTGS2—Crohn's disease	1.35e-05	0.000159	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.34e-05	0.000157	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—CXCL8—Crohn's disease	1.33e-05	0.000157	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL2RA—Crohn's disease	1.28e-05	0.000151	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GPX4—Crohn's disease	1.28e-05	0.00015	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—ALB—Crohn's disease	1.27e-05	0.00015	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.24e-05	0.000147	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GCKR—Crohn's disease	1.23e-05	0.000145	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.22e-05	0.000143	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—FADS1—Crohn's disease	1.22e-05	0.000143	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—FADS1—Crohn's disease	1.19e-05	0.00014	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GPX4—Crohn's disease	1.14e-05	0.000134	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—FADS1—Crohn's disease	1.12e-05	0.000132	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PTGS2—Crohn's disease	1.11e-05	0.000131	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GPX4—Crohn's disease	1.11e-05	0.000131	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—FADS1—Crohn's disease	1.11e-05	0.000131	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.1e-05	0.00013	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GCKR—Crohn's disease	1.1e-05	0.000129	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.09e-05	0.000128	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GCKR—Crohn's disease	1.07e-05	0.000126	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GPX4—Crohn's disease	1.05e-05	0.000123	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GPX4—Crohn's disease	1.04e-05	0.000122	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GCKR—Crohn's disease	1.01e-05	0.000119	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GCKR—Crohn's disease	1e-05	0.000118	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—ALB—Crohn's disease	9.97e-06	0.000117	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—ALB—Crohn's disease	9.56e-06	0.000113	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—FADS1—Crohn's disease	9.48e-06	0.000112	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—MTMR3—Crohn's disease	9.39e-06	0.000111	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TYK2—Crohn's disease	9.02e-06	0.000106	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GPX4—Crohn's disease	8.87e-06	0.000104	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.81e-06	0.000104	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTGS2—Crohn's disease	8.72e-06	0.000103	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—JAK2—Crohn's disease	8.61e-06	0.000101	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GCKR—Crohn's disease	8.57e-06	0.000101	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTGS2—Crohn's disease	8.36e-06	9.85e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.86e-06	9.25e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CXCL8—Crohn's disease	7.86e-06	9.25e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.7e-06	9.07e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—IL6—Crohn's disease	7.47e-06	8.8e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—FADS1—Crohn's disease	7.31e-06	8.61e-05	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.29e-06	8.59e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.17e-06	8.44e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.88e-06	8.1e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GPX4—Crohn's disease	6.85e-06	8.06e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GCKR—Crohn's disease	6.61e-06	7.79e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—STAT3—Crohn's disease	6.32e-06	7.44e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.27e-06	7.38e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—ALB—Crohn's disease	6.26e-06	7.37e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—ALB—Crohn's disease	6.25e-06	7.36e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.12e-06	7.21e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—ALB—Crohn's disease	5.83e-06	6.86e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTGS2—Crohn's disease	5.48e-06	6.45e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTGS2—Crohn's disease	5.47e-06	6.44e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.36e-06	6.31e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTGS2—Crohn's disease	5.1e-06	6e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ALB—Crohn's disease	4.54e-06	5.34e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ALB—Crohn's disease	4.53e-06	5.33e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL6—Crohn's disease	4.41e-06	5.2e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTGS2—Crohn's disease	3.97e-06	4.67e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTGS2—Crohn's disease	3.96e-06	4.66e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ALB—Crohn's disease	3.92e-06	4.62e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ALB—Crohn's disease	3.5e-06	4.12e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTGS2—Crohn's disease	3.43e-06	4.04e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ALB—Crohn's disease	3.42e-06	4.02e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ALB—Crohn's disease	3.22e-06	3.79e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ALB—Crohn's disease	3.19e-06	3.76e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTGS2—Crohn's disease	3.06e-06	3.61e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTGS2—Crohn's disease	2.99e-06	3.52e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.82e-06	3.32e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.79e-06	3.29e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ALB—Crohn's disease	2.73e-06	3.21e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.39e-06	2.81e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ALB—Crohn's disease	2.1e-06	2.48e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.84e-06	2.17e-05	CbGpPWpGaD
